Product: | Bezafibrate | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 5400 | ||||||||
CAS Number: | 41859-67-0 | ||||||||
Synonyms: | 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]-2-methylpropanoic acid | ||||||||
Pricing: |
|
||||||||
Formula: | C19H20ClNO4 | ||||||||
Chemical Purity: | >98% | ||||||||
Molecular Weight: | 361.82 | ||||||||
Structure: | |||||||||
Appearance: | Solid | ||||||||
Category: | Unlabeled Reference Standards | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Keep container tightly closed in a dry and well ventilated place |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Inoue, I., et al., Expression of peroxisome proliferator-activated receptor α (PPARα) in primary cultures of human vascular endothelial cells. Biochem. Biophys. Res. Commun. 246, 370-374 , (1998); Merck 14,1195 |
||||||||
MSDS: | |||||||||
Description: |
The peroxisome proliferator-activated receptor (PPAR) is a member of the steroid nuclear receptor superfamily. Bezafibrate is a peroxisome proliferator-activated receptor agonist for PPARα, PPARδ, and PPARγ. Lipoprotein lipase (LPL) activator. PPARgamma agonists, including Bezafibrate, have beneficial effects in the suppression of the inflammatory response during RSV infection and therefore might have clinical efficacy in the course of severe RSV-infection |